Beauvericin counteracted multi-drug resistant Candida albicans by blocking ABC transporters

Synthetic and Systems Biotechnology - Tập 1 - Trang 158-168 - 2016
Yaojun Tong1,2,3, Mei Liu1, Yu Zhang4, Xueting Liu1, Ren Huang4, Fuhang Song1, Huanqin Dai1, Biao Ren1,3, Nuo Sun1,5, Gang Pei1, Jiang Bian1, Xin-Ming Jia6, Guanghua Huang7, Xuyu Zhou1, Shaojie Li7, Buchang Zhang8, Takashi Fukuda9, Hiroshi Tomoda10, Satoshi Ōmura9, Richard D. Cannon11
1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
2The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, 2800, Denmark
3University of Chinese Academy of Sciences, Beijing, 100049, China
4Guangdong Laboratory Animals Monitoring Institute, Guangzhou 510260, China
5Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, DC 20057, US
6Department of Immunology, School of Medicine, Tongji University, Shanghai 200092, China
7State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
8Institute of Health Sciences, School of Life Sciences, Anhui University, Hefei 230601, China
9Research Center for Tropical Diseases, Kitasato Institute for Life Sciences, Kitasato University, Tokyo 108-8641, Japan
10Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan
11Sir John Walsh Research Institute, University of Otago, Dunedin 9016, New Zealand

Tài liệu tham khảo

Brown, 2012, Tackling human fungal infections, Science, 336, 647, 10.1126/science.1222236 Pfaller, 2007, Epidemiology of invasive candidiasis: a persistent public health problem, Clin Microbiol Rev, 20, 133, 10.1128/CMR.00029-06 Cui, 2015, Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans, Virulence, 6, 362, 10.1080/21505594.2015.1039885 Anderson, 2005, Evolution of antifungal-drug resistance: mechanisms and pathogen fitness, Nat Rev Microbiol, 3, 547, 10.1038/nrmicro1179 Cowen, 2008, The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype, Nat Rev Microbiol, 6, 187, 10.1038/nrmicro1835 Prasad, 2005, Multidrug resistance in yeast Candida, Int Rev Cytol, 242, 215, 10.1016/S0074-7696(04)42005-1 Prasad, 2006, Efflux pumps in drug resistance of Candida, Infect Disord Drug Targets, 6, 69, 10.2174/187152606784112164 Sanglard, 2003, Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents, Antimicrob Agents Chemother, 47, 2404, 10.1128/AAC.47.8.2404-2412.2003 Zhang, 2005 Aller, 2009, Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding, Science, 323, 1718, 10.1126/science.1168750 Lionta, 2014, Structure-based virtual screening for drug discovery: principles, applications and recent advances, Curr Top Med Chem, 14, 1923, 10.2174/1568026614666140929124445 Sterling, 2015, ZINC 15-ligand discovery for everyone, J Chem Inf Model, 55, 2324, 10.1021/acs.jcim.5b00559 Fukuda, 2004, New beauvericins, potentiators of antifungal miconazole activity, produced by Beauveria sp FKI-1366 – I. Taxonomy, fermentation, isolation and biological properties, J Antibiot, 57, 110, 10.7164/antibiotics.57.110 Zhang, 2007, High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections, Proc Natl Acad Sci USA, 104, 4606, 10.1073/pnas.0609370104 Mei, 2009, An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats, J Enzyme Inhib Med Chem, 24, 753, 10.1080/14756360802362041 Trott, 2010, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J Comput Chem, 31, 455 Dallakyan, 2015, Small-molecule library screening by docking with PyRx, Methods Mol Biol, 1263, 243, 10.1007/978-1-4939-2269-7_19 Song, 2010, Trichodermaketones A-D and 7-O-methylkoninginin D from the marine fungus Trichoderma koningii, J Nat Prod, 73, 806, 10.1021/np900642p Clinical and Laboratory Standards Institute, 2008 Wu, 2015, Systemic Candida parapsilosis infection model in immunosuppressed ICR mice and assessing the antifungal efficiency of fluconazole, Vet Med Int, 2015, 10.1155/2015/370641 Schwede, 2003, SWISS-MODEL: an automated protein homology-modeling server, Nucleic Acids Res, 31, 3381, 10.1093/nar/gkg520 Arnold, 2006, The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling, Bioinformatics, 22, 195, 10.1093/bioinformatics/bti770 Guex, 1997, SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling, Electrophoresis, 18, 2714, 10.1002/elps.1150181505 Pettersen, 2004, UCSF chimera – a visualization system for exploratory research and analysis, J Comput Chem, 25, 1605, 10.1002/jcc.20084 Schrodinger, 2010 Sanglard, 1996, Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors, Antimicrob Agents Chemother, 40, 2300, 10.1128/AAC.40.10.2300 Sanglard, 1997, Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene, Microbiology, 143, 405, 10.1099/00221287-143-2-405 Holmes, 2008, ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates, Antimicrob Agents Chemother, 52, 3851, 10.1128/AAC.00463-08 Decottignies, 1998, ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p, J Biol Chem, 273, 12612, 10.1074/jbc.273.20.12612 Lamping, 2007, Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae, Eukaryot Cell, 6, 1150, 10.1128/EC.00091-07 Ivnitski-Steele, 2009, Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p, Anal Biochem, 394, 87, 10.1016/j.ab.2009.07.001 Eliopoulos, 1991, 432 Chen, 2006, Induction of calcium influx from extracellular fluid by beauvericin in human leukemia cells, Biochem Biophys Res Commun, 340, 134, 10.1016/j.bbrc.2005.11.166 Jow, 2004, Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium, Cancer Lett, 216, 165, 10.1016/j.canlet.2004.06.005 Jia, 2008, RTA2, a novel gene involved in azole resistance in Candida albicans, Biochem Biophys Res Commun, 373, 631, 10.1016/j.bbrc.2008.06.093 Jia, 2009, RTA2 is involved in calcineurin-mediated azole resistance and sphingoid long-chain base release in Candida albicans, Cell Mol Life Sci, 66, 122, 10.1007/s00018-008-8409-3 Dai, 2009, Baicalein induces programmed cell death in Candida albicans, J Microbiol Biotechnol, 19, 803 Sharma, 2010, Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans, Biosci Rep, 30, 391, 10.1042/BSR20090151 Ames, 1975, Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test, Mutat Res, 31, 347, 10.1016/0165-1161(75)90046-1 Flamand, 2001, Mini mutagenicity test: a miniaturized version of the Ames test used in a prescreening assay for point mutagenesis assessment, Toxicol In Vitro, 15, 105, 10.1016/S0887-2333(01)00003-0 Bowlby, 2008, hERG (KCNH2 or Kv11.1) K+ channels: screening for cardiac arrhythmia risk, Curr Drug Metab, 9, 965, 10.2174/138920008786485083 Priest, 2008, Role of hERG potassium channel assays in drug development, Channels (Austin), 2, 87, 10.4161/chan.2.2.6004 Cosgrove, 2003, The impact of antimicrobial resistance on health and economic outcomes, Clin Infect Dis, 36, 1433, 10.1086/375081 Smith, 2007, Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation, Nat Chem Biol, 3, 549, 10.1038/nchembio.2007.27 Hiraga, 2005, Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae, Biochem Biophys Res Commun, 328, 1119, 10.1016/j.bbrc.2005.01.075 Tanabe, 2011, Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function, Mol Microbiol, 82, 416, 10.1111/j.1365-2958.2011.07820.x Sharom, 1998, Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation, Biochem J, 333, 621, 10.1042/bj3330621 Rizzuto, 2012, Mitochondria as sensors and regulators of calcium signalling, Nat Rev Mol Cell Biol, 13, 566, 10.1038/nrm3412 Kohanski, 2007, A common mechanism of cellular death induced by bactericidal antibiotics, Cell, 130, 797, 10.1016/j.cell.2007.06.049 Dwyer, 2009, Role of reactive oxygen species in antibiotic action and resistance, Curr Opin Microbiol, 12, 482, 10.1016/j.mib.2009.06.018 Liu, 2013, Cell death from antibiotics without the involvement of reactive oxygen species, Science, 339, 1210, 10.1126/science.1232751 Keren, 2013, Killing by bactericidal antibiotics does not depend on reactive oxygen species, Science, 339, 1213, 10.1126/science.1232688 Brown, 2016, Antibacterial drug discovery in the resistance era, Nature, 529, 336, 10.1038/nature17042 Baym, 2016, Multidrug evolutionary strategies to reverse antibiotic resistance, Science, 351, 10.1126/science.aad3292